Pfizer

XYNTHA

Manufacturer:

Pfizer

Xyntha HCPCS:

J7185

HCPCS Code Descriptor:

Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u.

Category:

J Code

Xyntha NDCs:

58394-0023-03, 58394-0024-03, 58394-0025-03, 58394-0022-03, 58394-0012-01, 58394-0016-03, 58394-0013-01, 58394-0014-01, 58394-0015-01

Primary Type:

Hematology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Xyntha:

XYNTHA is a Hematology drug manufactured by Pfizer and administered via the Intravenous route of administration. The J Code: J7185 is aligned to the drug XYNTHA.

ACCESS PRICING AND MORE BY REGISTERING

J7185 Added Date:

January 1, 2010

J7185 Effective Date:

January 1, 2010

J7185 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Xyntha billing and coding information.
Xyntha patient assistance information can be found through Pfizer Rx Pathways at the URL: https://www.pfizerrxpathways.com/
XYNTHA prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for XYNTHA. Please check back in a few weeks.